04 / GREEN RED BIO METABOLOME

No digestion required,
no dependence on enzymes

Enzyme power weakens with age. GRBM aims to be a metabolome cells use directly — not a substance that works only when enzymes do.

In plain words

Most foods, supplements and medicines we take are broken down, converted, absorbed and used only when enzymes do enough work. So a product's effect depends largely on the person's enzyme status.

But enzyme activity falls with age and with accumulated stress and disease. That is why products work poorly for exactly the elderly and patients who need help most.

GRBM has already passed through Vital Probiotics metabolism and been upgraded into a cell-recognizable bio-metabolome. So it requires no digestion, does not depend on enzymes, and gives the body's tissues and organs an opportunity to rest.

A metabolome cells recognize at once
A metabolome cells recognize at onceDigestion destroys the inherent properties of bio-substances and makes absorption vary with health status.

Three bioavailability advantages

No digestion required
01

No digestion required

Not an ingredient activated by digestion, but a metabolome already upgraded into a form cells recognize easily.

Not enzyme-dependent
02

Not enzyme-dependent

Carries genetic information cells recognize: External miRNA, bacterial sRNA, extracellular-vesicle RNA and gene-encoded peptides.

No chemical toxicity or heat denaturation
03

No chemical toxicity or heat denaturation

Many enzymes denature above about 57 °C. GRBM is made by biological metabolism without harsh chemicals or high heat.

Existing products vs. GRBM

Enzyme-dependent products vs. GRBM
Item Existing products (enzyme-dependent) Green Red BIO Metabolome
Mechanism Enzyme-dependent Aims at enzyme independence
Path in the body Used after digestion, breakdown and conversion Centered on direct use by cells
Effect of age Response varies widely with aging Pursues relatively consistent use even with age
Process Relies on heat and chemistry Non-heat, non-chemical ecological approach
Tissue burden Possible extra metabolic load Reduced load, tissue rest
Energy metabolism Butyrate pathway, ROS and aging substances Lactate–acetate pathway, no separate aging substances
Core value Works only with enzymes A metabolome cells use directly
Read moreCloseStructural constraints of conventional product development, and what "metabolic rest" means

Three structural constraints of conventional development

01

Heat sensitivity

Many biological enzymes risk denaturation above about 57 °C; heat-processed products struggle to keep biological function.

02

Mixed chemicals

Chemical treatment often enters extraction, purification and reformulation, and isomers can form.

03

Metabolic burden

The body spends extra energy processing enzyme-dependent substances — a burden in itself for a weakened body.

Metabolic rest — GRBM's own mechanism

GRBM is low-molecular, bio-based plant material converted into metabolites by mutualistic beneficial microbes. Because bioactive metabolites enter cells and are used directly, unnecessary metabolic load falls and tissues and organs gain a chance to rest. I believe this rest is the key that opens cellular metabolic realignment — the principle of the 12-week program.

Where it comes from Entering the body When cells use it Producing energy What remains Ordinary metabolite Metabolite produced bydigesting food absorbed afterdigestion needs the helpof enzymes butyratepathway ROS and otheraging substances GRBM metabolome Metabolome pre-metabolized byplants & good microbes absorbed directlywithout digestion used at once via thegenetic info it carries lactate–acetatepathway no separateaging substances
The paths of ordinary metabolites and the GRBM metabolome in the body

Why it is an investment value

As populations age, the market for "enzyme-dependent products" runs into the limits of efficacy, while the value of materials less bound by enzymes grows. Infants, the elderly, patients and astronauts — those for whom digestion and absorption are hardest — are GRBM's clearest customers.

This explanation is for understanding only and does not guarantee any specific product or treatment. Source: the developer's (Wooyoung Nam's) research.

PARTNERSHIP · INVESTMENT

The world's first true eco-bio platform technology —
we are looking for the one partner

After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.